Wegovy acta imitando una hormona llamada pptido 1 similar al glucagn (GLP-1) que se dirige a reas del cerebro que regulan el apetito y la ingesta de alimentos, indic el regulador estadounidense al anunciar su aprobacin
Important safety considerations include a boxed warning for thyroid C-cell tumors (contraindicated in patients with personal/family history of MTC or MEN2), and warnings regarding pancreatitis, gallbladder disease, and severe gastrointestinal disease
This includes observing safety protocols, using designated storage equipment, and ensuring all handling takes place within appropriate facilities
This limits the primary vial to one or two punctures and eliminates repeated contamination exposure
Translation to clinical use requires demonstrating superiority over existing therapies and establishing long-term safety through rigorous trials
Retatrutide is an investigational triple hormone receptor agonist that targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously
